We designed experiments to characterize the role of superoxide anions in the mediation of endothelium-dependent contractions in isolated canine basilar arteries. Rings with and without endothelium were suspended for isometric tension recording in Krebs-Ringer bicarbonate solution bubbled with 94% Oj-6% CO 2 (37°C, pH 7.4). Radioimmunoassay was used to determine the levels of cyclic GMP and cyclic AMP. Calcium ionophore A23187 (1(T 9 to 1(T 6 mol/L) caused concentration-dependent contractions. The removal of endothelium abolished the effect of A23187. Contractions to A23187 were reversed into relaxations in the presence of superoxide dismutase (150 U/mL) or the prostaglandin H 2 /thromboxane A 2 receptor antagonist SQ29548 (10~6 mol/L). Af G -nitro-Larginine methyl ester (3xlO~4 mol/L) augmented contractions to A23187. In rings with endothelium, A23187 (3 x 1(T 7 mol/L) significantly increased levels of both cyclic AMP and cyclic GMP. Indomethacin (10~5 mol/L) inhibited stimulatory effects of A23187 on cyclic AMP production. In contrast, indomethacin augmented A23187-induced production of cyclic GMP. Selective augmentation of cyclic GMP production by indomethacin appears to be due to protection of nitric oxide or a closely related molecule released following translocation of calcium into endothelial cells. Our findings suggest that (1) an increased concentration of calcium in endothelial cells may activate both cyclooxygenase and the L-arginine/nitric oxide pathway, (2) arachidonic acid metabolism via cyclooxygenase is a source of superoxide anions, and (3) superoxide anions may be responsible for impairment of balance between relaxing and contracting factors leading to contraction of underlying smooth muscle cells. (Hypertension. 1994^3:229-235.)
ndothelium-dependent contractions, mediated
by the activation of arachidonic acid metabolism via the cyclooxygenase pathway, have been described in arteries and veins. 1 The role of these contractions in the regulation of the cardiovascular system is unclear. However, selective impairment of endothelium-dependent relaxations associated with augmentation of endothelium-dependent contractions has been described in arteries removed from animals with high blood pressure or diabetes or after ischemiareperfusion or aging.
" 10
The canine basilar artery has been used as a model to study the mechanisms of endothelium-dependent contractions. In previous studies 11 ' 12 we provided evidence that translocation of calcium into endothelial cells of this artery causes activation of arachidonic acid metabolism with subsequent release of cyclooxygenase products and contraction of smooth muscle cells. Prostaglandin H 2 (PGH 2 ), thromboxane A 2 (TXA 2 ), and superoxide anions have been proposed as mediators of these contractions. 56 ' 1115 Superoxide anions are potent chemical inactivators of nitric oxide and inhibitors of prostacyclin synthesis. 16 -19 In contrast, they do not inhibit production of contractile prostanoids. 12 Thus, increased production of superoxide anions may impair the balance between relaxing and contracting factors released from endothelium and faReceived July 6, 1993; accepted in revised form November 11, 1993 .
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vor contraction of underlying smooth muscle cells. In the present study we examined the mechanisms of endothelium-dependent contractions to more precisely characterize the role of superoxide anions.
Methods
The experiments were performed on rings (4 mm in length) of basilar arteries taken from dogs (15 to 20 kg) anesthetized with pentobarbital sodium (30 mg/kg IV). All procedures followed were in accordance with institutional guidelines. The arteries were placed in modified Krebs-Ringer bicarbonate solution (control solution) containing (mmol/L) NaCl, 118.3; KC1,4.7; CaCl 2 ,2.5; MgSO 4 ,1.2; KH 2 PO 4 ,1.2; NaHCO 3 ,25.0; calcium EDTA, 0.026; and glucose, 11.1. In certain rings, the endothelium was removed mechanically. Each ring was connected to an isometric force transducer (Gould 3000) suspended in an organ chamber filled with 25 mL of control solution (37°C, pH 7.4), and gassed with 94% Oj-6% CO 2 . Isometric tension was recorded continuously.
The arteries were allowed to stabilize at a resting tension of 200 to 400 mg for 1 hour. Each ring was then gradually stretched to the optimal point of its length-tension curve (2.5 g) as determined by the contraction to uridine 5'-triphosphate (UTP, 10" 3 mol/L). The functional integrity of endothelium was tested by the presence of relaxations to vasopressin (10~7 mol/L). methacin (10~3 mol/L) were used to inhibit nitric oxide synthase(s) and prostanoid production, respectively, these also were present throughout the incubation period of 30 minutes. After 1 minute in the presence of A23187 (3xl(T 7 mol/L), all rings were removed from the solution and frozen in liquid nitrogen. Amersham cGMP and cAMP radioimmunoassay kits were used to perform the measurements.
20

Drugs
The following pharmacologic agents were used: calcium ionophore A23187 (Sigma), 9,ll-dideoxy-9a,lla-methanoepoxy-prostaglandin F^ (U46619, Cayman Chemical Co), indomethacin (Sigma), L-NAME (Sigma), papaverine hydrochloride (Sigma), pentobarbital sodium (Fort Dodge Laboratories), PGH 2 (BIOMOL Research Laboratories), superoxide dismutase (SOD) (from dog blood, 3000 U/mg protein, Sig-
, and UTP (Sigma). Stock solutions of the drugs were freshly prepared every day. Drugs were dissolved in distilled water such that volumes of less than 0.2 mL were added to the organ chambers. A stock solution of 10" 3 mol/L indomethacin was prepared in equal molar concentrations of Na 2 CO 3 . A stock solution of 10" 6 mol/L A23187 was prepared in 1.5 xlO~4 mol/L dimethyl sulfoxide. All concentrations are expressed as final molar (mol/L) concentration in the bath solution.
Concentration-response curves were obtained in a cumulative fashion. Several rings cut from the same artery were studied in parallel; only one concentration-response curve was made per preparation. Responses to the calcium ionophore A23187 were obtained during submaximal contractions to UTP (10" 5 mol/L). Responses to U46619 and PGH 2 were obtained in quiescent rings. Because L-NAME increased resting tension, care was taken to match the contractions induced by UTP in control and treated rings. The incubation time was 30 minutes for indomethacin, 15 minutes for L-NAME and SQ29548, and 5 minutes for SOD. The contractions were expressed as a percentage of the contractions induced by UTP (10~5 mol/L) or KC1 (60 mmol/L), whereas relaxations were expressed as a percentage of maximal relaxations induced by papaverine (3xlO~4 mol/L).
Statistical Analysis
Results are expressed as mean±SEM; in each set of experiments n equals the number of animals studied. Statistical evaluation of the data was performed by Student's t test for paired observations. A value of /"<.05 was considered statistically significant. 
Results
Endothelium-Dependent Contractions to A23187
In rings of canine basilar arteries contracted with UTP (1CT 5 mol/L), the calcium ionophore A23187 (MT 9 to lfr 6 mol/L) caused concentration-dependent contractions. The removal of endothelium abolished the effect of A23187 (Fig 1) . In rings with endothelium, indomethacin (1(T 5 mol/L), 12 SOD (150 U/mL), and the PGH 2 /TXA 2 receptor antagonist SQ29548 (10~6 mol/L) each converted contractions to A23187 to relaxations (Figs 2 and 3 ). In the presence of SQ29548, relaxations to A23187 were significantly bigger than relaxations obtained in the presence of SOD (Table 1 ). In contrast, the nitric oxide synthase inhibitor L-NAME (3 x 10" 4 mol/L) significantly augmented endothelium-dependent contractions to A23187 (area under the curve, 583±36 and 793±77, n=8 for control and L-NAME-treated rings, respectively; P<.05). Furthermore, SOD did not affect A23187-induced contractions in the presence of L-NAME (Fig 4) .
In quiescent rings without endothelium, the PGH 2 / TXA 2 receptor agonists PGH 2 (10~6 mol/L) or U46619 (10~1 0 to 10" 6 mol/L) caused contractions. These con- tractions were abolished by SQ29548 (1(T 6 mol/L, Fig  4) . SOD (150 U/mL) did not affect contractions to PGH 2 (Fig 5) .
Endothelium-Dependent Relaxations to A23187
The endothelium-dependent contractile effects of A23187 superimposed on contractions established with UTP were converted to relaxations by SQ29548 (Fig 3 5 mol/L) or L-NAME (3x10-* mol/L) significantly reduced relaxations to A23187 (Figs 6 and 7) . Indomethacin plus L-NAME produced significantly more inhibition of A23187-induced relaxations than indomethacin or L-NAME alone (Fig 8,  Table 2 ). However, endothelium-dependent relaxations to A23187 were not abolished by indomethacin plus L-NAME.
In rings without endothelium contracted with UTP (HT 5 mol/L), A23187 (10"' to 10" 6 mol/L), both alone and in the presence of SOD (150 U/mL) or SQ29548 (10~6 mol/L), did not cause any change in tension (Table 3) . SOD (150 U/mL) and SQ29548 did not affect contractions to UTP in rings with or without endothelium (10~5 mol/L, see figure legends).
A23187-Induced Production of Cyclic AMP and Cyclic GMP
In rings with endothelium, A23187 (3xlO~7 mol/L) significantly increased production of cAMP and cGMP (Fig 9) . Indomethacin (10~5 mol/L) inhibited A23187-induced production of cAMP. In contrast, indomethacin augmented production of cGMP in response to A23187 (Fig 9) . The stimulatory effect of A23187 on the production of cyclic nucleotides was inhibited in the presence of L-NAME (3xlO~4 mol/L, Fig 9) .
Discussion
The present study demonstrates that in isolated canine basilar arteries, translocation of calcium into endothelial cells simultaneously activates both arachidonic acid metabolism via cyclooxygenase and the production of nitric oxide from L-arginine. This conclusion is supported by several lines of evidence: (1) Endotheliumdependent contractions to A23187 are converted to endothelium-dependent relaxations by the PGH 2 /TXA 2 receptor antagonist SQ29548; (2) A23187 significantly 
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Fra 7. Une graph shows concentration-response curves to calcium ionophore A23187 in canine basilar arteries with endothelium in the absence and presence of W Q -nitro-c-arginine methyl ester (LNAME) (3x10~4 mol/L). Relaxations were obtained during contractions to uridine 5'-triphosphate (10~5 mol/L) or LNAME (3x10" 4 mol/L) in rings treated with SQ29548 (10"° mol/L). Data are mean±SEM and expressed as percent of maximal relaxation induced by papaverine (3x10~4 mol/L; 10O%=3.6±0. 4 [n=8] and 3.5+0.5 g [n=8] for SQ29548 and SQ29548 plus LNAME, respectively). *Slgnificant difference (P<.05) between the two curves.
increased production of cyclic nucleotides in the arterial wall; (3) cyclooxygenase inhibition with indomethacin decreased A23187-induced production of cAMP but augmented production of cGMP; and (4) nitric oxide synthase inhibition with L-NAME significantly augmented A23187-induced contractions and inhibited the production of cyclic nucleotides. These results clearly demonstrate that in large canine cerebral arteries, endothelium-dependent relaxations to A23187 are masked by simultaneous release of contracting factors.
Inhibition of A23187-induced production of cAMP in the presence of indomethacin may be explained by decreased vasodilator prostanoid production, possibly prostacyclin. 12 On the other hand, selective augmentation of cGMP production by indomethacin appears to for SQ29548 alone and in the presence of indomethacin plus L-NAME, respectively). *Significant difference (P<,05) between the two curves. *P<.05 vs indomethacln+L-NAME.
TABLE 2. Comparison of Effect of Indomethacin or L-NAME With Effect of Indomethacin Plus L-NAME on
be due to protection of nitric oxide from inactivation by superoxide anions. Prostaglandin H (PGH) synthase oxidizes a large number of compounds, and these oxidations are followed by chain reactions involving free radical generation. 2126 The enzyme-centered free radical intermediates generated in the PGH synthase oxidation of arachidonic acid react with NADH + to form the radical • NAD. This radical in turn is known to react with oxygen to produce superoxide anion. 27 ' 28 The concentration and capacity of PGH synthase to produce prostaglandins is 20 times higher in endothelial cells than in smooth muscle. 29 Thus, these studies together with our results suggest that an increased concentration of calcium in endothelial cells may lead to the generation of superoxide anions via activation of the cyclooxygenase pathway. This conclusion is consistent with the demonstrated ability of the endothelial cyclooxygenase pathway in cerebral arteries to produce superoxide anions. 30 A nitric oxide synthase inhibitor, L-NAME, prevented the stimulatory effect of A23187 on the production of cyclic nucleotides. The inhibition of cGMP production is best explained by the inactivation of nitric oxide synthase and decreased production of nitric oxide. 20 On the other hand, the inhibition of cAMP may be due to an increased concentration of superoxide anions in the presence of L-NAME with a subsequent inhibitory effect on prostacyclin synthase.
-
19 However, it is not likely that L-NAME stimulates a cyclooxygenasedependent superoxide production. 31 In fact, in our preparations indomethacin did not reduce but further augmented L-NAME-induced inhibition of endothelium-dependent relaxations to A23187.
Endothelium-dependent contractions were converted to relaxations in the presence of the PGH 2 /TXA 2 receptor antagonist SQ29548. Furthermore, SQ29548 abolished contractions caused by PGH 2 or U46619 in rings without endothelium, whereas SOD did not affect PGH 2 -induced contractions, indicating a direct activation of PGH 2 /TXA 2 receptors in the smooth muscle cells without the involvement of superoxide anions. The inhibitory effect of SQ29548 on endothelium-dependent contractions demonstrates that the activation of PGH 2 / TXA 2 receptors in the smooth muscle plays a key role in the contractile process. 32 Our present findings support this concept, demonstrating that the contractile effect of A23187 appears to be due to stimulation of the release of contractile prostanoids. Identical observations were made in studies performed on aorta from spontaneously hypertensive rats (SHR) and diabetic rabbits and on rabbit aorta exposed to elevated concentrations of glucose. Impairment of endothelium-dependent relaxations was associated with augmented endotheliumdependent contractions. ' 34 In agreement with our results, endothelium-dependent relaxations were restored by cyclooxygenase inhibition or PGH 2 /TXA 2 receptor blockade.
Endothelium-dependent relaxations to A23187 were significantly reduced by indomethacin or L-NAME, suggesting that the relaxations were mediated by the production and release of nitric oxide and prostacyclin or some other vasodilator prostanoid. Indomethacin plus L-NAME further reduced relaxations to A23187 but did not abolish the effect of A23187. Relaxation resistant to inhibition by indomethacin plus L-NAME may be mediated by a hyperpolarizing factor or some other unknown substance released from endothelium. 35 The present study confirmed our previous findings that SOD converts endothelium-dependent contractions evoked by A23187 to relaxations. 12 In canine basilar arteries, superoxide anions produce a modest contraction of smooth muscle, 12 -36 implying that chemical inactivation of endothelial nitric oxide is a major mechanism responsible for the contractile effect of superoxide anions. In contrast, generation of superoxide anions by xanthine plus xanthine oxidase causes contractions of aorta from SHR comparable to the maximal contractions induced by a depolarizing solution of 60 mmol/L KC1. 5 These contractions were observed in aortas without endothelium, suggesting that free radicals are very potent contractile agents in smooth muscle cells of hypertensive animals. Because superoxide anions may cross cell membrane, 30 it is not possible to rule out the possibility that in some blood vessels, increased production of this free radical in endothelium may favor contraction of smooth muscle not only by inactivation of endothelial nitric oxide but also by direct activation of the contractile process in smooth muscle cells. On the other hand, the earlier observation of an increased production of prostacyclin in the presence of SOD plus catalase 12 would suggest that relaxations to prostacyclin may be responsible for the inhibitory effect of SOD. However, the interpretation of this finding is complicated by the fact that prostacyclin produces both relaxation (3xl(r 10 to 3xlO~8 mol/L) and contraction (1CT 7 to 10" 5 mol/L) of the isolated canine basilar artery. 37 Furthermore, the lack of an inhibitory effect of SOD in the presence of L-NAME indicates that the observed increase in the concentration of prostacyclin cannot explain the reversal of A23187-induced contractions. By contrast, the cyclic nucleotide data and the inhibitory effect of SOD alone provide strong evidence that superoxide anions modulate the endothelium-mediated responses to calcium ionophore primarily via inactivation of nitric oxide. Endothelium-dependent contractions mediated by cyclooxygenase have been described in resistance arteries of young SHR before the development of manifest hypertension. 15 Interestingly, these contractions were not affected by a PGH 2 /TXA 2 receptor antagonist but could be abolished with an inhibitor of superoxide anion -") in mediation of endothelium-dependent contractions. Translocation of calcium into endothelial cells by the lonophore may activate both cyclooxygenase and nitric oxide (NO) synthase pathways. Effect of relaxing factors is masked by simultaneous release of contractile factors. Arachidonic acid metabolism via cyclooxygenase is a source of superoxide anions that may be responsible for impairment of balance between relaxing and contracting factors leading to contraction of underlying smooth muscle cells. -indicates inactivation of NO; PGG 2 , prostaglandin G 2 ; PGH 2 , prostaglandin H 2 ; TXAj, thromboxane Aj,; PGI 2 , prostacyclin; t, increase; cAMP, cyclic AMP; and cGMP, cyclic GMP.
production. Intravenous injections of SOD reduced arterial blood pressure in SHR but not in Wistar-Kyoto normotensive rats. 3 * Furthermore, a correlation between the expression of endothelium-dependent contractions and increase in arterial blood pressure has been reported in SHR. 39 These findings strongly support the concept that the production of superoxide anions mediated by cyclooxygenase activation may play a role in the development of high arterial tone in hypertension. Indeed, as in SHR, 2 treatment of hypertensive patients with indomethacin improves endothelium-dependent relaxations to acetylcholine. 40 Our findings demonstrate the existence of superoxide anion-mediated interaction between endothelial cyclooxygenase and the L-arginine/nitric oxide pathway (Fig  10) . In pathological conditions, increased production of superoxide anions could be responsible for an impairment of balance between relaxing and contracting factors, leading to expression of endothelium-dependent contractions. The precise role of superoxide anions in the etiology of vascular diseases including hypertension remains to be determined.
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